Follistatin 344 — a truncated, highly active form of the naturally occurring protein follistatin — is used in research settings for its potent ability to bind and inhibit myostatin and activins, proteins that limit muscle growth and regulate tissue repair. By blocking myostatin signaling, Follistatin 344 can promote increased muscle fiber size and enhanced regenerative responses in preclinical models. Researchers investigate it for applications in muscle-wasting conditions, regeneration biology, and metabolic modulation.
Key points:
Mechanism: High-affinity myostatin and activin inhibition.
Effects observed in studies: Muscle hypertrophy, improved regeneration, potential metabolic benefits.
Status: Primarily an experimental research compound; not approved for human therapeutic use. Requires controlled laboratory handling and adherence to ethical/regulatory guidelines.
Safety considerations: Long-term effects, dosing, and off-target consequences are not fully characterized; clinical use remains investigational.
Intended for laboratory and preclinical research — consult relevant regulatory and institutional protocols before obtaining or using Follistatin 344.
Follistatin 344 — a truncated, highly active form of the naturally occurring protein follistatin — is used in research settings for its potent ability to bind and inhibit myostatin and activins, proteins that limit muscle growth and regulate tissue repair. By blocking myostatin signaling, Follistatin 344 can promote increased muscle fiber size and enhanced regenerative responses in preclinical models. Researchers investigate it for applications in muscle-wasting conditions, regeneration biology, and metabolic modulation.
Key points:
Mechanism: High-affinity myostatin and activin inhibition.
Effects observed in studies: Muscle hypertrophy, improved regeneration, potential metabolic benefits.
Status: Primarily an experimental research compound; not approved for human therapeutic use. Requires controlled laboratory handling and adherence to ethical/regulatory guidelines.
Safety considerations: Long-term effects, dosing, and off-target consequences are not fully characterized; clinical use remains investigational.
Intended for laboratory and preclinical research — consult relevant regulatory and institutional protocols before obtaining or using Follistatin 344.
